Global Open-Angle Glaucoma Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Open-Angle Glaucoma Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Open-Angle Glaucoma Therapeutics by Type
- 1.3.1 Overview: Global Open-Angle Glaucoma Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Open-Angle Glaucoma Therapeutics Consumption Value Market Share by Type in 2023
- 1.3.3 Prostaglandin Analogs (PGAs)
- 1.3.4 Combination of PGAs
- 1.3.5 Other
- 1.4 Global Open-Angle Glaucoma Therapeutics Market by Application
- 1.4.1 Overview: Global Open-Angle Glaucoma Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Research Institute
- 1.4.5 Other
- 1.5 Global Open-Angle Glaucoma Therapeutics Market Size & Forecast
- 1.6 Global Open-Angle Glaucoma Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Open-Angle Glaucoma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Open-Angle Glaucoma Therapeutics Market Size by Region, (2019-2030)
- 1.6.3 North America Open-Angle Glaucoma Therapeutics Market Size and Prospect (2019-2030)
- 1.6.4 Europe Open-Angle Glaucoma Therapeutics Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size and Prospect (2019-2030)
- 1.6.6 South America Open-Angle Glaucoma Therapeutics Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Aerie Pharmaceuticals Inc.
- 2.1.1 Aerie Pharmaceuticals Inc. Details
- 2.1.2 Aerie Pharmaceuticals Inc. Major Business
- 2.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product and Solutions
- 2.1.4 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Aerie Pharmaceuticals Inc. Recent Developments and Future Plans
- 2.2 Allergan Plc
- 2.2.1 Allergan Plc Details
- 2.2.2 Allergan Plc Major Business
- 2.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Product and Solutions
- 2.2.4 Allergan Plc Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Allergan Plc Recent Developments and Future Plans
- 2.3 Bausch Health Companies, Inc.
- 2.3.1 Bausch Health Companies, Inc. Details
- 2.3.2 Bausch Health Companies, Inc. Major Business
- 2.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product and Solutions
- 2.3.4 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Bausch Health Companies, Inc. Recent Developments and Future Plans
- 2.4 Novartis AG
- 2.4.1 Novartis AG Details
- 2.4.2 Novartis AG Major Business
- 2.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Product and Solutions
- 2.4.4 Novartis AG Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novartis AG Recent Developments and Future Plans
- 2.5 Pfizer Inc.
- 2.5.1 Pfizer Inc. Details
- 2.5.2 Pfizer Inc. Major Business
- 2.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Product and Solutions
- 2.5.4 Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Pfizer Inc. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Open-Angle Glaucoma Therapeutics Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Open-Angle Glaucoma Therapeutics by Company Revenue
- 3.2.2 Top 3 Open-Angle Glaucoma Therapeutics Players Market Share in 2023
- 3.2.3 Top 6 Open-Angle Glaucoma Therapeutics Players Market Share in 2023
- 3.3 Open-Angle Glaucoma Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Open-Angle Glaucoma Therapeutics Market: Region Footprint
- 3.3.2 Open-Angle Glaucoma Therapeutics Market: Company Product Type Footprint
- 3.3.3 Open-Angle Glaucoma Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Open-Angle Glaucoma Therapeutics Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Open-Angle Glaucoma Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Open-Angle Glaucoma Therapeutics Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Open-Angle Glaucoma Therapeutics Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Open-Angle Glaucoma Therapeutics Consumption Value by Type (2019-2030)
- 6.2 North America Open-Angle Glaucoma Therapeutics Consumption Value by Application (2019-2030)
- 6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Country
- 6.3.1 North America Open-Angle Glaucoma Therapeutics Consumption Value by Country (2019-2030)
- 6.3.2 United States Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 6.3.3 Canada Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Open-Angle Glaucoma Therapeutics Consumption Value by Type (2019-2030)
- 7.2 Europe Open-Angle Glaucoma Therapeutics Consumption Value by Application (2019-2030)
- 7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Country
- 7.3.1 Europe Open-Angle Glaucoma Therapeutics Consumption Value by Country (2019-2030)
- 7.3.2 Germany Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 7.3.3 France Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 7.3.5 Russia Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 7.3.6 Italy Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Consumption Value by Region (2019-2030)
- 8.3.2 China Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 8.3.3 Japan Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 8.3.5 India Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 8.3.7 Australia Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Open-Angle Glaucoma Therapeutics Consumption Value by Type (2019-2030)
- 9.2 South America Open-Angle Glaucoma Therapeutics Consumption Value by Application (2019-2030)
- 9.3 South America Open-Angle Glaucoma Therapeutics Market Size by Country
- 9.3.1 South America Open-Angle Glaucoma Therapeutics Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
- 10.3.4 UAE Open-Angle Glaucoma Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Open-Angle Glaucoma Therapeutics Market Drivers
- 11.2 Open-Angle Glaucoma Therapeutics Market Restraints
- 11.3 Open-Angle Glaucoma Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Open-Angle Glaucoma Therapeutics Industry Chain
- 12.2 Open-Angle Glaucoma Therapeutics Upstream Analysis
- 12.3 Open-Angle Glaucoma Therapeutics Midstream Analysis
- 12.4 Open-Angle Glaucoma Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Open-Angle Glaucoma Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Open-Angle Glaucoma Therapeutics industry chain, the market status of Hospital (Prostaglandin Analogs (PGAs), Combination of PGAs), Clinic (Prostaglandin Analogs (PGAs), Combination of PGAs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Open-Angle Glaucoma Therapeutics.
Regionally, the report analyzes the Open-Angle Glaucoma Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Open-Angle Glaucoma Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Open-Angle Glaucoma Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Open-Angle Glaucoma Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Prostaglandin Analogs (PGAs), Combination of PGAs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Open-Angle Glaucoma Therapeutics market.
Regional Analysis: The report involves examining the Open-Angle Glaucoma Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Open-Angle Glaucoma Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Open-Angle Glaucoma Therapeutics:
Company Analysis: Report covers individual Open-Angle Glaucoma Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Open-Angle Glaucoma Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Open-Angle Glaucoma Therapeutics. It assesses the current state, advancements, and potential future developments in Open-Angle Glaucoma Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Open-Angle Glaucoma Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Open-Angle Glaucoma Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Prostaglandin Analogs (PGAs)
Combination of PGAs
Other
Market segment by Application
Hospital
Clinic
Research Institute
Other
Market segment by players, this report covers
Aerie Pharmaceuticals Inc.
Allergan Plc
Bausch Health Companies, Inc.
Novartis AG
Pfizer Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Open-Angle Glaucoma Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Open-Angle Glaucoma Therapeutics, with revenue, gross margin and global market share of Open-Angle Glaucoma Therapeutics from 2019 to 2024.
Chapter 3, the Open-Angle Glaucoma Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Open-Angle Glaucoma Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Open-Angle Glaucoma Therapeutics.
Chapter 13, to describe Open-Angle Glaucoma Therapeutics research findings and conclusion.